ITGA2B and systemic lupus erythematosus: However, it may be worth measuring the anti-GPIb ELISPOT assay in patients who are suspected to have primary ITP or secondary ITP in association with SLE, but are negative for anti-GPIIb/IIIa antibody-producing cells, because there is a >30% chance for obtaining the positive result.